ADCETRIS (Seattle Genetics, Inc.)
Welcome to the PulseAid listing for the ADCETRIS drug offered from Seattle Genetics, Inc.. This CD30-directed Antibody Interactions [MoA],CD30-directed Immunoconjugate [EPC],Immunoconjugates [Chemical/Ingredient],Microtubule Inhibition [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Seattle Genetics, Inc. |
| NON-PROPRIETARY NAME: | brentuximab vedotin |
| SUBSTANCE NAME: | BRENTUXIMAB VEDOTIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | CD30-directed Antibody Interactions [MoA],CD30-directed Immunoconjugate [EPC],Immunoconjugates [Chemical/Ingredient],Microtubule Inhibition [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2011-08-25 |
| END MARKETING DATE: | 0000-00-00 |
ADCETRIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | ADCETRIS from Seattle Genetics, Inc. |
| LABELER NAME: | Seattle Genetics, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/10.5mL) |
| START MARKETING DATE: | 2011-08-25 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 51144-050_d23ca83a-7e53-c6f9-b58f-06d033a0ad1e |
| PRODUCT NDC: | 51144-050 |
| APPLICATION NUMBER: | BLA125388 |
Other BRENTUXIMAB VEDOTIN Pharmaceutical Manufacturers / Labelers:
